Safety of Antitheilerial Drug Buparvaquone in Rams

Authors

  • Nermin Isik Department of Parasitology, Faculty of Veterinary Medicine, University of Selcuk, Konya, Turkey.
  • Ozlem Derinbay Ekici Department of Parasitology, Faculty of Veterinary Medicine, University of Selcuk, Konya, Turkey.
  • Ceylan Ilhan Department of Parasitology, Faculty of Veterinary Medicine, University of Selcuk, Konya, Turkey.
  • Devran Coskun Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Selcuk, Konya, Turkey.

DOI:

https://doi.org/10.22456/1679-9216.86688

Abstract

Background: Theileriosis is a tick-borne disease caused by Theileria strains of the protozoan species. Buparvaquone is the mostly preferred drug in the treatment theileriosis, while it is safety in sheep, has not been detailed investigated. It has been hypothesized that buparvaquone may show side effects and these effects may be defined some parameters measured from blood in sheep when it is used at the recommended dose and duration. The aim of this research was to determine the effect of buparvaquone on the blood oxidative status, cardiac, hepatic and renal damage and bone marrow function markers.

Materials, Methods & Results: In this study, ten adult (> 2 years) Akkaraman rams were used. Healthy rams were placed in paddocks, provided water ad libitum, and fed with appropriate rations during the experiment. Buparvaquone was administered at the dose of 2.5 mg/kg (IM) intramuscularly twice at 3-day intervals. Blood samples were obtained before (0. h, Control) and after drug administration at 0.25, 0.5, 1, 2, 3, 4 and 5 days. The blood samples were transferred to gel tubes, and the sera were removed (2000 g, 15 min). During the study, the heart rate, respiratory rate, and body temperature were measured at each sampling time. In addition, the animals were clinically observed. Plasma oxidative status markers (Malondialdehyde, total antioxidant status, catalase, glutathione peroxidase, superoxide dismutase), serum cardiac (Troponin I, creatine kinase-MBmass, lactate dehydrogenase), hepatic (Alkaline phosphatase, alanine aminotransferase, aspartate aminotransferase, gamma glutamyltransferase, total protein, albumin, globulin) and renal (Creatinine, blood urea nitrogen) damage markers and hemogram values (white blood cell, red blood cell, platelet, hemogram, hematocrit) were measured. Buparvaquone caused statistically significantly (P < 0.05) increases in the troponin I and blood urea nitrogen levels and fluctuations in alkaline phosphatase activity, but there was no any statistically significance difference determined in the other parameters.

Discussion: In this study, buparvaquone was administered two times at a dose of 2.5 mg/kg (IM) at 3-day intervals. Although the result was not statistically significant (P > 0.05), it was determined that buparvaquone gradually increased the levels of the main oxidative stress marker, MDA, by approximately 2.8 fold. CAT and GPX levels were also found to have decreased by 2.2 fold. Buparvaquone may cause lipid peroxidation by producing free radicals. Some other antiprotozoal drugs may affect the oxidative status and may increase MDA level and decrease SOD level. In this study, MDA, which is an indicator of lipid peroxidation in vivo, was used to partially detect developing lipid peroxidation. Changes in the levels of reduced GPX and CAT enzymes could be attributed to their use in mediating the hydrogen peroxide detoxification mechanisms. The absence of significant changes in the TAS levels in this study suggests that buparvaquone may partially induce oxidative stress by producing hydrogen peroxide, but no significant changes occurred in the oxidative stress level because of the high antioxidant capacity of sheep. In this study, buparvaquone caused a statistically significant increase (P < 0.05) in the level of Tn-I, which is a marker of specific cardiac damage (P < 0.05), whereas there was no statistically (P > 0.05) significant increase in CK-MBmass. Tn-I and CK-MB levels, which are used to define heart damage in humans, have been successfully used to determine heart damage in sheep. In this research study, the statistically significant increases in Tn-I but not CK-MBmass levels could be considered indicative of mild cardiac damage.

Downloads

Download data is not yet available.

References

Abolaji A.O., Osedeme F. & Olusemire O. 2014. Artesunate-amodiaquine combination therapy in the absence of malarial parasite infection induces oxidative damage in female rats. Cell Biochemistry and Function. 32(3): 303-308.

Bulbul A. 2013. Reference hematological values. In: Elmas M. (Ed). Sheep & Goat Hand Book. Konya: Billur Press, pp.509-515.

Dogan F. 2011. Pharmacovigilance in veterinary profession. Eurasian Journal of Veterinary Sciences. 27(1): 19-25.

Ekici O.D. & Isik N. 2011. Investigation of the cardiotoxicity of imidocarb in lambs. Revue de Médecine Vétérinaire. 162(1): 40-44.

Ekici O.D. & Isik N. 2012. Alterations of blood parameters after intramuscular administration of imidocarb in healthy lambs. Drug and Chemical Toxicology. 35(2): 162-166.

Elbe H., Dogan Z., Taslidere E., Cetin A. & Turkoz Y. 2015. Beneficial effects of quercetin on renal injury and oxidative stress caused by ciprofloxacin in rats: A histological and biochemical study. Human and Experimental Toxicology. 35(3): 276-281.

Er A., Dik B., Corum O. & Cetin G. 2013. Cardiac safety of diclofenac at single dose in ram. Scientific World Journal. ID: 808731.

Er A., Dik B., Corum O., Cetin G & Yazar E. 2015. Effect of halofuginone on blood thiobarbituric acid reactive substances, testosterone and 13,14-dihydro-15-keto-prostaglandin F2α levels in male yearling sheep. Journal of Applied Life Sciences International. 2(3): 126-133.

Fromm R.E. 2007. Cardiac troponins in the intensive care unit: Common causes of increased levels and interpretation. Critical Care Medicine. 35(2): 584-588.

Guler T., Celeb N., Surer H., Yilmaz F.M., Guler S., Sipit T., Duranay M. & Yucel D. 2004. Pulmoner tüberkülozlu hastalarda serum total antioksidan kapasite. Turkiye Klinikleri Journal of Medical Sciences. 24(6): 316-322.

Han J., Cai H., Wang J. & Liu G. 2013. Detrimental effects of metronidazole on the liver of freshwater common carp (Cyprinus carpio L.). Bullutein of Environmental Contamination and Toxicology. 91(4): 444-449.

Ilgin S., Can O.D., Atli O., Ucel U.I., Sener E. & Guven I. 2015. Ciprofloxacin-induced neurotoxicity: evaluation of possible underlying mechanisms. Toxicology Mechanisms and Methods. 25(5): 374-381.

Kaufmann J. 1996. Parasitic infections of domestic animals: A diagnostic manual. Berlin: BirkshauserVerlag, pp.23-143.

Kerr M.G. 2002. Clinical biochemistry. In: Kerr M.G. (Ed). Veterinary Laboratory Medicine. 2nd edn. London: Black Well Science, pp.50-198.

Larue C., Calzolari C., Bertinchant J.P., Leclercq F., Grolleau R. & Pau B. 1993. Cardiac-specific immuneenzymometric assay of troponin I in the early phase of acute myocardial infarction. Clinical Chemistry. 39(6): 972-979.

Lin T., Yu S., Chen Y. & Chen W. 2014. Integrated biomarker responses in Zebra fish exposed to sulfonamides. Environmental

Toxicology and Pharmacology. 38(2): 444-452.

McHardy N. 1992. Butalex (buparvaquone): A new therapeutic for theileriosis. In: Dolan T.T. (Ed). Recent Developments in the Research and Control Theileria annulata. Nairobi: ILRAD, 59p.

Naziroglu M., Saki C.E. & Sevgili M. 1999. The effect of buparvaquone treatment on the levels of some antioxidant

vitamins, lipid peroxidation and glutathione peroxidase in cattle with theileriosis. Zentralbl Veterinarmed B. 46(4): 233-239.

Ogut S & Atay E. 2012. Aging and oxidative stress. S D Ü Tıp Fakültesi Dergisi. 19: 68-74.

Ozler M., Oter S. & Korkmaz A. 2009. The use of ozone gas for medical purposes. TAF Preventive Medicine Bulletin. 8(1): 59-64.

Panteghini M. 2000. Present issues in the determination of troponins and other markers of cardiac damage. Clinical Biochemistry. 33(3): 161-166.

Reece W.O. 2015. Body temperature and its regulation. In: Reece W.O. (Ed). Dukes’ Physiology of Domestic Animals. 13th edn. Ames: Wiley Blackwell, pp.150-154.

Riedesel D.H. & Engen R.L. 2015. The Heart and Vasculature: Gross Structure and Basic Properties. In: Reece W.O. (Ed). Dukes’ Physiology of Domestic Animals. 13th edn. Ames: Wiley Blackwell, pp.287-302.

Sezer K. & Keskin M. 2014. Role of the free oxygen radicals on the pathogenesis of the diseases. Fırat Universitesi Saglik Bilimleri Veteriner Dergisi. 28(1): 49-56.

Sirmatel F., Duygu F., Celik H., Selek S., Sirmatel O., Gursoy B. & Eris F.N. 2009. Evaluation of total oxidative level and total antioxidant capacity in cases with chronic viral hepatitis. Klimik Journal. 22(3): 92-96.

Tabakoglu E. & Durgut R. 2013. Oxidatıve stress in veterinary medicine and effects in some important diseases. Adana Veteriner Kontrol Enstitüsü Müdürlüğü Dergisi. 3(1): 69-75.

Taylorr M.A., Coop R.L. & Wall R. 2007. Veterinary Parasitology. 3rd edn. London: Blackwell Publishing, pp.51-151.

Turgut K. 2000. Clinical Enzymology. In: Turgut K. (Ed). Veterinary Clinic Laboratory Diagnosis. 2nd edn. Konya:

Bahcivanlar press, pp.185-189.

Yazar E., Birdane Y.O., Elmas M., Tras B. & Bas A.L. 2002. Effect of tilmicosin on serum creatine kinase, creatine kinase-MB and troponin I levels in new Zealand white rabbits. Archiv fur Geflugelkunde. 66: 237-239.

Yazar E. & Tras B. 2002. Serbest oksijen radikalleri, antioksidan enzimler ve antibiyotikler. Türk Veteriner Hekimler Dergisi. 14: 42-44.

Yazar E. 2018. Antiprotozoon therapy. In: Yazar E. (Ed). Veterinary Drug Guide. Istanbul: Nobel tip press, pp.206-213.

Published

2018-01-01

How to Cite

Isik, N., Ekici, O. D., Ilhan, C., & Coskun, D. (2018). Safety of Antitheilerial Drug Buparvaquone in Rams. Acta Scientiae Veterinariae, 46(1), 7. https://doi.org/10.22456/1679-9216.86688

Issue

Section

Articles

Most read articles by the same author(s)